- Home
- FBIN vs RYTM Comparison
FBIN vs RYTM Comparison
Compare FBIN & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBIN | RYTM |
|---|---|---|
| Founded | 1988 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 6.4B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | FBIN | RYTM |
|---|---|---|
| Price | $55.47 | $105.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | $63.75 | ★ $129.92 |
| AVG Volume (30 Days) | ★ 1.8M | 621.5K |
| Earning Date | 02-05-2026 | 02-25-2026 |
| Dividend Yield | ★ 1.83% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.67 | N/A |
| Revenue | ★ $4,489,900,000.00 | $174,334,000.00 |
| Revenue This Year | $0.11 | $47.40 |
| Revenue Next Year | $2.21 | $56.14 |
| P/E Ratio | $21.25 | ★ N/A |
| Revenue Growth | N/A | ★ 54.92 |
| 52 Week Low | $44.04 | $45.91 |
| 52 Week High | $75.68 | $122.20 |
Technical Indicators
Market Signals| Indicator | FBIN | RYTM |
|---|---|---|
| Relative Strength Index (RSI) | 48.75 | 49.11 |
| Support Level | $58.56 | $101.47 |
| Resistance Level | $62.15 | $109.02 |
| Average True Range (ATR) | 2.33 | 5.40 |
| MACD | -0.34 | -0.00 |
| Stochastic Oscillator | 38.81 | 49.49 |
Price Performance
Historical ComparisonAbout FBIN Fortune Brands Innovations Inc.
Fortune Brands Innovations is a leading home and security products company that has three reportable segments. The company's $2.6 billion water segment, led by the Moen brand, sells faucets, showers, and other plumbing fixtures; the $1.4 billion outdoors segment primarily sells entry doors under the Therma-Tru brand name and Fiberon-branded patio decking; and the $700 million security segment sells locks and other security devices under the Master Lock, SentrySafe, Yale, and August brand names.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.